CD8A and ovarian serous adenocarcinoma: Univariate survival analysis was performed to assess the prognostic value of the 320 genes identified as differentially expressed between high and low CD8+ TIL tumours, using 157 late-stage serous ovarian cancer patients previously profiled at our institute (Crijns et al, 2009).